Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q8IQ
|
|||
Former ID |
DNC010116
|
|||
Drug Name |
1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one
|
|||
Synonyms |
CHEMBL566830; 2-(N,N-Dimethylamino)-3'-chloropropiophenone; 740079-95-2; 1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one; SCHEMBL769582; BDBM50302908; AKOS009983839; 2-(N,N-Dimethylamino)-3''-chloropropiophenone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H14ClNO
|
|||
Canonical SMILES |
CC(C(=O)C1=CC(=CC=C1)Cl)N(C)C
|
|||
InChI |
1S/C11H14ClNO/c1-8(13(2)3)11(14)9-5-4-6-10(12)7-9/h4-8H,1-3H3
|
|||
InChIKey |
UYZAXUWVJGHEFL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
Norepinephrine transporter (NET) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. J Med Chem. 2010 Mar 11;53(5):2204-14. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.